demand industri market
continu strength china mid-teen growth coupl w/
divers busi food materi less pharma
geographi minim tariff impact today present promis
slow start pharma due hold back capital-expenditure spend larg
na custom expect improv exemplifi
despit bounc back flattish perform india remain drag
core along w/ soft food industri
thesi updat water remark consist
compani time even respect respond
intermitt bout quarterli inconsist come less
stellar first quarter investor prepar anoth disappoint
print particularli given rash sell side downgrad
learn lesson one end result particularli
strong given macro certainli better fear
reflect today share ralli despit fy ep growth move lower
fx relat mind help de-risk fy lower half
rang look do-abl given extra day although question
still remain two notabl risk back half india na
larg pharma respect capital-expenditure improv sequenti
manag expect could see achiev high end
core guid think would prove challeng
said expect continu aggress cadenc buy-back
provid line sight consist ep roll noth
much chang mind fundament valuat
start look increasingli stretch rel basi wat
premium extrem level vs past decad see
risk revert back toward norm china tariff risk flare
growth macro begin re-norm given dynam
reiter rate lower pt expect share
calm de-rat squeez today posit
continu next page
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
support outlook solid macro across end market ex tough comp strong
chang impress strength across tool
revenu in-lin due broad base global demand strong ta perform
product develop new offer sequenti improv weak
instrument instrument ta instrument
constant currenc reiter fx tw lower vs
interest lower mm vs mm prior
w/ rest come potenti repo
ep lower midpoint vs prior
lower fx tw neutral vs prior
constant currenc fx tw lower tw vs prior
vs consensu
ep fx hw vs consensu
asia driven high growth china offset flat india growth
china
strength pharma food materi
india growth flat although improv weak
return growth pharma partial off-set weak industri
confid improv indian biz custom regain
america us growth canada latam off-set soft
europ industri particularli strong partial off-set pharma
continu next page
pharma grew driven dd growth china off-set slowdown budget releas
develop countri
strong yoy growth larg molecul biz
industri grew driven strong ta sale w/ good volum
softer demand food industri off-set strength chemic
 grew due broad base global demand despit weak biomed
announc acquisit ms imag bolster direct
bn share repo author period impact repo plan
mm repurchas
bought back alreadi may potenti spend
rate w/ total buyback plan evalu cours
valuat methodolog base mix discount cash flow analysi rel valuat multipl
risk valuat includ regulatori risk overal market risk well unforeseen event relat individu cover
compani broader sector includ new competit product technolog
laboratori corp america hold
articl articl
time dissemin juli et
analyst ross muken luke sergott primarili respons prepar research report attest follow
view opinion render research report reflect person view subject compani issuer part
research analyst compens directli relat specif recommend view research report
